Specific therapy and medicament using integrin ligands for treating cancer

Details for Australian Patent Application No. 2008207095 (hide)

Owner Merck Patent GmbH

Inventors Picard, Martin Andreas; Stupp, Roger; Krueger, Stefan; Nippgen, Johannes; Weller, Michael; Harstrick, Andreas; Goodman, Simon; Grimm, Ulrike

Agent Davies Collison Cave

Pub. Number AU-A-2008207095

PCT Pub. Number WO2008/087025

Priority PCT/ US2007/01446 18.01.07 US; 07014070.2 18.07.07 EP

Filing date 17 January 2008

Wipo publication date 24 July 2008

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/087025 Priority application(s): WO2008/087025

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207104-Cyclodextrin formulations

2008207076-Disposable hygiene item in the form of a pair of knickers, with an improved fit